Novogen Limited Announces Closing of Rights Issue … replied by Helen.zhang @ Wed, 03 Jun 2015 16:04:24 +0800

Novogen Limited Announces Closing of Rights Issue Entitlement Offer and Notice of ShortfallSYDNEY /PRNewswire/ — US-Australian drug discovery and development company, Novogen Limited (ASX:NRT; NASDAQ:NVGN), announced today the non-renounceable pro-rata rights issue entitlement announced on 21 April 2015 (Rights Issue) was completed successfully.The Rights Issue offered up to 58,971,207 new shares at an issue price of $0.30 per share and […]